Research Group: iGO – Health Technology Assessment in Gastrointestinal Oncology
Thematic Line: TL2 – Clinical & Translational Research addresses
Hub: Faculty of Medicine of the University of Porto
Research Areas: Gastroenterology and Hepatology, Surgery, Oncology, Endocrinology and Metabolism
updated on 19/03/2018
Mário Dinis-Ribeiro is the Principal Investigator of the Thematic Line 2 – Clinical and Translational Research and of the Research group iGO – Health Technology Assessment in Gastrointestinal Oncology of CINTESIS.
He graduated in Medicine (1996) and earned his Doctorate Degree (2005) from the Faculty of Medicine of the University of Porto (FMUP). He then specialised in Gastroenterology at the Portuguese Institute of Oncology of Porto (IPO-Porto).
He is the Head of the Gastroenterology Service of IPO-Porto, Guest Full Professor of the Department of Community Medicine, Health Information and Decision (MEDCIDS) at FMUP, where he also coordinates the Master Programme in Health Evidence and Decision, and several other undergraduate courses.
His research interests focus on the development of predictive models and diagnosis procedures for early detection and maintenance of gastrointestinal tumours through endoscopic resection of the mucous membrane and within that field he leads several inter-institutional national and international projects. Mário Dinis-Ribeiro is a researcher of reference in his field, having authored about 200 scientific articles, part of which were published in some of the most high-profile journals in the field of Gastroenterology.
Currently, he is President of the European Society of Gastrointestinal Endoscopy (ESGE), Vice-president of the Portuguese Society of Digestive Endoscopy, Chief Co-editor of the journal Endoscopy, Associate Editor of the GE-Portuguese Journal of Gastroenterology and a member of the Scientific Council of the United European Gastroenterology (UEG).
TITLE: Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)
AUTHORS: Dinis Ribeiro, M ; Areia, M ; de Vries, AC; Marcos Pinto, R ; Monteiro Soares, M; O’Connor, A; Pereira, C; Pimentel Nunes, P ; Correia, R ; Ensari, A; Dumonceau, JM; Machado, JC ; Macedo, G ; Malfertheiner, P; Matysiak Budnik, T; Megraud, F; Miki, K; O’Morain, C; Peek, RM; Ponchon, T; …More
SOURCE: ENDOSCOPY, VOLUME: 44, ISSUE: 1, PUBLISHED: 2012
TITLE: Meta-analysis on the validity of pepsinogen test for gastric carcinoma, clysplasia or chronic atrophic gastritis screening
AUTHORS: Dinis Ribeiro, M ; Yamaki, G; Miki, K; Costa Pereira, A ; Matsukawa, M; Kurihara, M;
SOURCE: JOURNAL OF MEDICAL SCREENING, VOLUME: 11, ISSUE: 3, PUBLISHED: 2004
TITLE: Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients
AUTHORS: Barros Silva, JD; Leitao, D; Afonso, L; Vieira, J; Dinis Ribeiro, M ; Fragoso, M; Bento, MJ; Santos, L ; Ferreira, P; Rego, S; Brandao, C; Carneiro, F ; Lopes, C; Schmitt, F ; Teixeira, MR ;
SOURCE: BRITISH JOURNAL OF CANCER, VOLUME: 100, ISSUE: 3, PUBLISHED: 2009
TITLE: Current practice with endoscopic submucosal dissection in Europe: position statement from a panel of experts
AUTHORS: Deprez, PH; Bergman, JJ; Meisner, S; Ponchon, T; Repici, A; Dinis Ribeiro, M ; Haringsma, J;
SOURCE: ENDOSCOPY, VOLUME: 42, ISSUE: 10, PUBLISHED: 2010
TITLE: Magnification chromoendoscopy for the diagnosis of gastric intestinal metaplasia and dysplasia
AUTHORS: Dinis Ribeiro, M ; da Costa Pereira, A ; Lopes, C ; Lara Santos, L ; Guilherme, M ; Moreira Dias, L; Lomba Viana, H; Ribeiro, A; Santos, C; Soares, J; Mesquita, N; Silva, R; Lomba Viana, R;
SOURCE: GASTROINTESTINAL ENDOSCOPY, VOLUME: 57, ISSUE: 4, PUBLISHED: 2003
Doctoral Program in Clinical Research and Health Services – PDICSS